drugset / Trial / NCT01013454

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin

NCT01013454

Phase 1 Completed 12 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This study will evaluate the single-dose pharmacokinetics, safety, and tolerability of a varenicline patch applied to the skin.

Timeline

Start
2009-12
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 6 mg Topical

Indications

No indication recorded.